Who should avoid Covaxin jab? Bharat Biotech lists out medical conditions
Those with a history of allergies, bleeding disorders and on medication that affect the immune system have been warned not to take the Covaxin shot by its maker Bharat Biotech.
The vaccine manufacturer on Monday (January 18) released a factsheet, mentioning who should not take the vaccine, two days after the central government rolled out its vaccination drive.
Earlier, the Health ministry had barred pregnant and lactating women and those on immune-suppressants or suffering from immune deficiency from taking the vaccine. People with HIV, cancer patients on chemotherapy, and those on steroids come under the immune-suppressed category.
Related news: On Day 3, 1.48L receive COVID-19 jabs; 2 dead, but Centre says no linkÂ
Bharat Biotech has advised people suffering from fever, those having bleeding disorders or on blood thinners, those having a history of allergy as well as pregnant and lactating women to avoid the Covaxin jab.
Also, people who have received a dose of the COVID-19 vaccine from another company cannot be administered a Covaxin shot.
The pharma major has advised individuals to reveal before the vaccinator or officer supervising the vaccination, about any pre-existing medical condition before getting the jab.
The factsheet also mentions that severe allergic reactions including difficulty in breathing, swelling of face and throat, fast heart-beat, rashes on body, dizziness and weakness are a few symptoms that people may experience after the vaccination.
Side effects like pain, swelling or itching of the area where the injection has been administered, body ache, headache, fever, weakness, rashes, nausea and vomiting are the side effects listed out by Bharat Biotech in its factsheet.
“Additionally, there is a remote chance that the Covaxin could cause a severe allergic reaction. For this reason, your vaccination provider will ask you to stay for 30 minutes after each dose of vaccination at the place where you received your vaccine for monitoring after vaccination,” the factsheet says.
Related news: 29 die in Norway post COVID-19 vaccination, here’s what’s happening
The company said follow up would be conducted on the recipients for a period of three months after being administered the second dose of the vaccine. “In case of any serious adverse events, vaccine recipients will be provided with a medically recognised standard of care in the government designated and authorised centres/hospital. The compensation for the serious adverse event will also be provided,” the factsheet added.
The factsheet comes in the light of at least 580 people reporting adverse reactions after taking the vaccine jab as part of the government’s programme.
